Nicholas A. Saccomano

Insider Reports History

Entity
Individual
Location
3200 Walnut Street, Boulder, CO
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas A. Saccomano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. President and CEO, Director Employee Stock Option (right to buy) 542K Oct 4, 2024 Direct
Reneo Pharmaceuticals, Inc. President and CEO, Director Class A Common Stock 4.56K Oct 4, 2024 Direct

Insider Reports Filed by Nicholas A. Saccomano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 6 $0 4 Oct 8, 2024 President and CEO, Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 President and CEO, Director